Effects of carbamazepine in aquatic biota.

Environ Sci Process Impacts

Université Reims Champagne Ardenne, UMR-I 02 SEBIO, 51100 Reims, France.

Published: February 2022

Carbamazepine (CBZ) is one of the most common pharmaceuticals found in the aquatic environment. Here, we reviewed studies in aquatic animals highlighting that CBZ affected ROS homeostasis but also the neuroendocrine system, cell viability, immunity, reproduction, feeding behavior and growth. Notably, the acetylcholinesterase activity was modified by concentrations of the order of ng L CBZ. At ≥10 μg L, data pointed that CBZ triggered the production of ROS, modifying the activity of antioxidant enzymes and produced a significant cellular stress at concentrations ≥100 μg L. However, the response appeared species-, organ- and time-dependent, and was impacted by different experimental conditions and the origin of animals. In this context, this review discusses the available data and proposes future research priorities.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d1em00328cDOI Listing

Publication Analysis

Top Keywords

effects carbamazepine
4
carbamazepine aquatic
4
aquatic biota
4
biota carbamazepine
4
cbz
4
carbamazepine cbz
4
cbz common
4
common pharmaceuticals
4
pharmaceuticals aquatic
4
aquatic environment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!